Chiral Baclofen Synthesis via Michael Addition and Chiral Auxiliary
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing the chiral form of Baclofen, (R)-(+)-β-(Aminomethyl)-4-chlorobenzenepropanoic acid, are inefficient with low overall yields and high costs, making them commercially uncompetitive.
Innovation Solution
A novel method involving the reaction of p-chlorocinamic acid with a chiral auxiliary compound, followed by Michael addition, hydrolysis, and reduction to obtain optically pure (R)-Baclofen with improved yield and reduced costs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the conventional resolution method with (S)-MBA is used, then (R)-Baclofen can be obtained, but the overall yield is only 9.2% making it commercially uncompetitive
Solution Approach 1:
The patent changes the chemical parameters of the synthesis route by using p-chlorocinamic acid as the starting material instead of racemic 3-(p-chlorophenyl)glutaramide, and employs a different chiral auxiliary compound (formula II) with specific structural parameters (R1-R3 groups) to achieve higher yield and improved manufacturing efficiency
Solution Approach 2:
The patent performs preliminary action by first forming a diastereomeric salt through reaction of p-chlorocinamic acid with the chiral auxiliary compound (formula II) before performing the Michael addition and subsequent steps, which enables better control of stereochemistry and improves overall yield
2Manufacturing precision
If multiple steps are performed to achieve optical purity, then (R)-Baclofen with high enantiomeric excess is obtained, but the process becomes complex and costly
Solution Approach 1:
The patent uses a chiral auxiliary compound (formula II) as an intermediary substance that temporarily incorporates chirality into the molecule during the synthesis process. This intermediary enables the formation of optically pure (R)-Baclofen through diastereomeric salt formation and selective Michael addition, while allowing for simplification of the overall process by avoiding more complex resolution methods
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves higher yields and lower production costs, resulting in optically pure (R)-Baclofen, addressing the inefficiencies of existing processes.
Implementation Method 1
reacting p-chlorocinamic acid with a chiral auxiliary compound of formula II to form a compound of formula III
Implementation Method 2
performing Michael addition of nitromethane to the compound of formula III to give a compound of formula IV
Implementation Method 3
performing hydrolysis of the compound of formula IV to obtain a compound of formula V
Implementation Method 4
reducing nitro group of the compound of formula V to yield (R)-Baclofen of formula I
Data Source
AI summary
The present invention provides a novel method for preparing chiral Baclofen with higher yield, higher e.e. value, and lower cost via chiral Michael addition.